Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 7Neoplasms 4Breast Neoplasms 4Recurrence 3Colonic Neoplasms 3Rectal Neoplasms 2Neoplasm Metastasis 2Tuberous Sclerosis 1Seizures 1Rectal Diseases 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplastic Cells, Circulating 1Neoplasms by Site 1Nasopharyngeal Carcinoma 1NSCLC 1Multiple Myeloma 1Lung Neoplasms 1Intestinal Neoplasms 1Intestinal Diseases 1Inflammation 1Gastrointestinal Neoplasms 1Gastrointestinal Hemorrhage 1Gastrointestinal Diseases 1Epilepsy 1Digestive System Neoplasms 1Digestive System Diseases 1Colonic Diseases 1Cognitive Dysfunction 1Carcinoma, Squamous Cell 1

Interventions

Vigabatrin 1Therapeutic Touch 1Sirolimus 1Neuropsychological Tests 1Medical Marijuana 1Fluid Therapy 1Aspirin 1Anticonvulsants 1Activator Appliances 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Epilepsy × Aspirin × Clear all
NCT03356769 2020-06-09

Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex

Peking Union Medical College Hospital

Phase 2 Unknown
98 enrolled

Epilepsy, Seizures, Tuberous Sclerosis, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡